Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @dgingery
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @dgingery
-
Derrick proslijedio/la je Tweet
Pharma Is Priority As GSK Confirms Split With Consumer http://bit.ly/398w9gM
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our take on
#SOTU: Drug Pricing Avoids The Limelight During State Of The Union Addresshttps://pink.pharmaintelligence.informa.com/articles/2020/02/04/drug-pricing-avoids-the-limelight-during-state-of-the-union-address …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As well as BsUFA III. I can't wait for the talks to begin...https://pink.pharmaintelligence.informa.com/PS141515/BsUFA-III-Could-Regulatory-Science-Research-Emerge-With-Other-Tweaks …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Here's our preview of the PDUFA VII negotiations:https://pink.pharmaintelligence.informa.com/PS141549/PDUFA-VII-Will-Gene-Therapys-Rise-Influence-Talks …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@PharmaPinkSheet unveiled a four-story preview of the upcoming user fee reauthorization process today. Here's a graphic looking at schedule:https://pink.pharmaintelligence.informa.com/PS141551/Predicting-The-User-Fee-Reauthorization-Schedule …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@US_FDA Kluetz at#OCEProject2025: the drug label is the most important document you've never read.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@US_FDA OCE's Pazdur at#OCEProject2025 ... We don't set policy on twitter or facebook. If you have an issue "come on down" and talk to us.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Derrick proslijedio/la je Tweet
Welcome to
@theNCI, Dr. Satish Gopal. I look forward to working with you in leading our global cancer research efforts.https://twitter.com/NCIGlobalHealth/status/1224446433878663168 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Will there really be cake
@FDAOncology!?https://twitter.com/FDAOncology/status/1224713002022248452 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Derrick proslijedio/la je Tweet
Visible Particles, Drug Shortages, DSCSA Spotlighted In CDER’s 2020 Quality/GMP Guidance Agendahttps://pink.pharmaintelligence.informa.com/articles/2020/02/01/visible-particles-drug-shortages-dscsa-spotlighted-in-cders-2020-qualitygmp-guidance-agenda …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check this out too: AstraZeneca’s Roxadustat And The Challenge Of Shifting Medicare Coverage Policyhttps://pink.pharmaintelligence.informa.com/articles/2020/02/03/astrazenecas-roxadustat-and-the-challenge-of-shifting-medicare-coverage-policy …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bonus Tuesday reading: Belgian Law Seeks To Tackle Drug Shortageshttps://pink.pharmaintelligence.informa.com/articles/2020/02/03/belgian-law-seeks-to-tackle-drug-shortages …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More Tuesday reading: Novel Virus Brings Novel Threats To Global Pharmaceutical Manufacturinghttps://pink.pharmaintelligence.informa.com/articles/2020/02/02/novel-virus-brings-novel-threats-to-global-pharmaceutical-manufacturing …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Part 2-our story on the guidance on promotion of biologics and biosimilars:https://pink.pharmaintelligence.informa.com/PS141620/Biosimilar-Information-Wars-Draft-Guidance-Seeks-To-Clamp-Down-On-Efforts-To-Hinder-Uptake-In-The-US …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Part 1 of our two-story package on yesterday's
@US_FDA biologics-biosimilars agreement with@FTC:https://pink.pharmaintelligence.informa.com/PS141619/FDA-FTC-Join-Forces-To-Eliminate-Barriers-To-Biosimilar-Competition …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@US_FDA releases development guidance for rare disease Sanfilippo Syndrome: https://www.fda.gov/media/134893/download …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More onboarding at
@US_FDA ...https://twitter.com/FDAJobs/status/1224413000712495104 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Derrick proslijedio/la je Tweet
Novel Virus Brings Novel Threats To Global Pharmaceutical Manufacturing http://bit.ly/394V4BO
#PinkSheetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.